|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.42 USD | +3.37% |
|
+10.16% | +8.50% |
| Jul. 12 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| Jul. 10 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Consensus Astellas Pharma Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
